Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain

Total article views   HTML views PDF downloads Totals
11,982 Dovepress* 10,864+ 1,851 12,715
PubMed Central* 1,118 322 1,440
Totals 11,982 2,173 14,155
*Since 4 October 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 0 4

View citations on PubMed Central and Google Scholar